THE POWER OF PROTEASOME INHIBITION
DEAD

Serial Number

78225868

Owner

MILLENNIUM PHARMACEUTICALS, INC.

Attorney

David Ehrlich

Filing Date

Mar 14, 2003

Add to watchlist:

No watchlists yet
View on USPTO

THE POWER OF PROTEASOME INHIBITION Trademark

Serial Number: 78225868

THE POWER OF PROTEASOME INHIBITION is a trademark filed by MILLENNIUM PHARMACEUTICALS, INC. on March 14, 2003. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

MILLENNIUM PHARMACEUTICALS, INC. (425 trademarks)

40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139

Entity Type: 03

Trademark Details

Filing Date

March 14, 2003

Registration Date

Not Registered

Published for Opposition

June 22, 2004

Goods & Services

Medical services and medical diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress

Research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; consultation services, namely, providing consultation to others via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology; providing on-line computer databases via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 10, 2007 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 7, 2007 ABN6
SOU EXTENSION 5 GRANTED
Jun 15, 2007 EX5G
SOU EXTENSION 5 FILED
Mar 6, 2007 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 6, 2007 EEXT
SOU EXTENSION 4 GRANTED
Oct 5, 2006 EX4G
SOU EXTENSION 4 FILED
Sep 13, 2006 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 13, 2006 EEXT
SOU EXTENSION 3 GRANTED
Mar 20, 2006 EX3G
SOU EXTENSION 3 FILED
Feb 28, 2006 EXT3
PAPER RECEIVED
Feb 28, 2006 MAIL
SOU EXTENSION 2 GRANTED
Oct 4, 2005 EX2G
PAPER RECEIVED
Sep 16, 2005 MAIL
SOU EXTENSION 2 FILED
Sep 13, 2005 EXT2
SOU EXTENSION 1 GRANTED
Apr 18, 2005 EX1G
PAPER RECEIVED
Mar 15, 2005 MAIL
SOU EXTENSION 1 FILED
Mar 10, 2005 EXT1
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 29, 2004 COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 29, 2004 COAR
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 14, 2004 NOAM
PUBLISHED FOR OPPOSITION
Jun 22, 2004 PUBO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 18, 2004 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 18, 2004 TCCA
NOTICE OF PUBLICATION
Jun 2, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2004 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2004 CRFA
PAPER RECEIVED
Feb 26, 2004 MAIL
NON-FINAL ACTION E-MAILED
Aug 24, 2003 GNRT
ASSIGNED TO EXAMINER
Aug 15, 2003 DOCK